3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
3
Prostatic Neoplasms
2
Neoplasms
2
Smoking
1
Pulmonary Disease, Chronic Obstructive
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Ototoxicity
1
Neoplastic Cells, Circulating
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Leukemia, Myeloid, Acute
1
Kidney Neoplasms
1
Hyperlipoproteinemia Type II
1
Hematologic Neoplasms
1
Hemangioma, Cavernous, Central Nervous System
1
Hearing Loss
1
Head and Neck Neoplasms
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Colorectal Neoplasms
1
Colitis, Ulcerative
1
Cardiotoxicity
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Advanced Renal Cell Carcinoma (RCC)
1
Interventions
Whole-Body Irradiation
7
fludarabine
6
Mycophenolic Acid
6
Cyclophosphamide
6
fludarabine phosphate
5
Sirolimus
4
Cyclosporine
4
Peripheral Blood Stem Cell Transplantation
3
Cyclosporins
3
ibrutinib
2
acalabrutinib
2
Rituximab
2
Melphalan
2
venetoclax
1
treosulfan
1
tafasitamab
1
obinutuzumab
1
Valganciclovir
1
Therapeutics
1
Tacrolimus
1
Stem Cell Transplantation
1
Positron-Emission Tomography
1
Polymerase Chain Reaction
1
Patient Reported Outcome Measures
1
Mesna
1
Magnetic Resonance Spectroscopy
1
Lenalidomide
1
Hematopoietic Stem Cell Transplantation
1
Granulocyte Colony-Stimulating Factor
1
Ganciclovir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Prolymphocytic
×
Atorvastatin
×
1 year
×
Clear all
No trials found.